Skip to main content

Press releases | February 5, 2025

Fried Frank acted as counsel to BofA Securities as financial advisor to Nevro Corp. (NYSE: NVRO) in its $250 million acquisition by Globus Medical (NYSE: GMED). Globus Medical is a leading musculoskeletal solutions company. Nevro Corp. is a global medical device company. 

The Fried Frank team was led by partner Roy Tannenbaum. 


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.